FOXL2 and neoplasm: Expanding studies to investigate ERM proteins, AMH/inhibin dynamics, proliferation indices, and FOXL2 status across tumor subtypes holds promise for enhancing prognostic stratification and informing tailored postoperative management in equine practice.